UCART22 Phase 1 dataset and late-stage development strategy expected in the third quarter of 2025; Orphan Drug Designation (ODD) and Rare ...

Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today an ...

Lundbeck has gained orphan drug designation (ODD) from Japan’s Ministry of Health, Labor and Welfare (MHLW) for amlenetug to ...

SpringWorks Therapeutics is working on new potential indications for its IP portfolio while running additional trials. See ...

European researchers propose diversifying diets with novel foods (NF), underutilized crops (NUS), and invasive species (IAS) to combat biodiversity loss and food insecurity, balancing ecological ...

A live audio webcast of the fireside chat can be accessed through the Investors section of the Company’s website at www.mereobiopharma.com/investors. An archived replay of the webcast will be ...

FDA, EMA grant BIOX-101 ODD status to treat intracerebral hemorrhagic stroke (ICH)ODD status may expedite drug candidate development and ...

CEO and managing director Dr Anthony Filippis said the company was delighted to have received the positive opinion for orphan designation of NTI164 in Rett syndrome for Europe. “There are no ...

STOCKHOLM, Feb. 27, 2025 /PRNewswire/ -- Sobi® (STO: SOBI), today announced that the U.S. Food and Drug Administration (FDA) has accepted the supplemental Biologics License Application (sBLA) for ...

Orphan Girl Children’s Theater Presents "The NeverEnding Story" based on the adaptation of Michael Ende’s beloved book "The NeverEnding Story," made famous by its 1984 film adaptation.

Twitter: @JBickertonUK. You can get in touch with James by emailing [email protected] U.S. Vice President JD Vance sent shockwaves across Europe in February when he used his speech at the ...